Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Intellia Thera CS (NTLA)

Intellia Thera CS (NTLA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
5 Cathie Wood Stocks That Remain Overvalued Despite the Market Correction

Cathie Wood stocks have been foundering for the past few months owing to volatile market conditions caused in-part by aggressive Federal Reserve interest rate hikes. So, given their companies’ bleak...

NTLA : 47.71 (+1.64%)
PATH : 17.13 (+3.57%)
ROKU : 96.87 (+2.14%)
SHOP : 391.33 (+8.52%)
TDOC : 32.91 (+6.61%)
Intellia (NTLA) Q1 Loss Wider Than Expected, Revenues Beat

Intellia Therapeutics (NTLA) posts wider-than-expected Q1 loss while sales beat the mark. NTLA continues to advance its pipeline with developmental programs.

REGN : 657.15 (-0.31%)
ALKS : 29.48 (+2.11%)
FOLD : 7.42 (+2.06%)
NTLA : 47.71 (+1.64%)
Intellia Therapeutics, Inc. (NTLA) Reports Q1 Loss, Tops Revenue Estimates

Intellia Therapeutics, Inc. (NTLA) delivered earnings and revenue surprises of -76.58% and 8.80%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?...

NTLA : 47.71 (+1.64%)
ANIP : 29.92 (+2.54%)
Intellia Therapeutics Announces First Quarter 2022 Financial Results and Highlights Recent Company Progress

Presented updated interim data from ongoing Phase 1 study in patients with transthyretin (ATTR) amyloidosis with polyneuropathy, demonstrating a single...

NTLA : 47.71 (+1.64%)
Drug/Biotech Stocks Q1 Earnings Due on May 5: VRTX, ZTS & More

Let's look at the five biotech/drug companies, slated to release quarterly results on May 5.

ENDP : 0.5800 (-6.47%)
VRTX : 255.45 (+1.23%)
ZTS : 158.63 (-0.14%)
NTLA : 47.71 (+1.64%)
VIR : 24.93 (+9.78%)
Incyte (INCY) Lags Q1 Earnings and Revenue Estimates

Incyte (INCY) delivered earnings and revenue surprises of -3.51% and 4%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

INCY : 74.34 (+1.29%)
NTLA : 47.71 (+1.64%)
Intellia Therapeutics Names Muna Bhanji, R.Ph., to its Board of Directors

CAMBRIDGE, Mass., May 02, 2022 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on developing...

NTLA : 47.71 (+1.64%)
Intellia Therapeutics Presents Preclinical Data Demonstrating Advancements in its CRISPR-Engineered Allogeneic Platform at the 2022 Keystone Symposia’s Precision Genome Engineering Conference

Data highlight proprietary allogeneic cell engineering platform capable of creating immune-evading T cells and deployable for TCR-T and CAR-T cell...

NTLA : 47.71 (+1.64%)
Intellia Therapeutics to Hold Conference Call to Discuss First Quarter 2022 Earnings and Company Updates

CAMBRIDGE, Mass., April 28, 2022 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing company focused...

NTLA : 47.71 (+1.64%)
5 Beaten-Down Biotech Stocks Cathie Wood Loves

Renowned investor Cathie Wood of ARK Invest is known for her eye for stocks with enormous upside potential. Despite recent macro headwinds, the biotech industry is expected to grow tremendously in 2022,...

BEAM : 33.94 (+5.96%)
CRSP : 56.49 (+3.16%)
DNA : 2.52 (+3.70%)
FATE : 22.40 (+2.61%)
NTLA : 47.71 (+1.64%)

Barchart Exclusives

Value Tech Stocks Favored with Market Turmoil
With the sell-off in technology stocks deepening, investors are flocking to “value” technology stocks as safe-haven from market turmoil. As a result, international Business Machines (IBM ), Hewlett Packard Enterprises Co. (HPE ), and HP Inc. (HPQ ) have eked out returns of as much as 2% this year, handily... Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar